Feed NVS
NV

Novartis NVS · NYSE

$161.47 +0.23% (+$0.37)

Market cap
$304.2B
Enterprise value
$345.6B
P/E
23.8x
Forward P/E
17.8x
PEG
1.2x
P/S
5.5x
P/FCF
19.2x
EV/EBITDA
15.5x
ROIC
13.9%
Gross margin
74.4%
Net margin
22.9%
Dividend yield
2.94%
Payout ratio
70.2%
Net debt/EBITDA
1.9x
Beta
0.42
Free float
96.9%

About the company

Novartis AG is a Swiss global pharmaceutical company with a broad portfolio of medicines and healthcare products. The company is one of the leading players in the pharmaceutical industry and operates worldwide. Novartis focuses on the development, manufacturing, and distribution of innovative medicines in various therapeutic areas, including oncology, cardiology, ophthalmology, neurology, and others. The company also specializes in the production and sale of generic drugs. Novartis dedicates significant efforts to research and development of new treatment options to help improve the quality of life for patients around the world. The company actively collaborates with medical professionals and institutions to ensure the best care for patients. Novartis AG (NVS) shares are an attractive choice for investors who follow the pharmaceutical industry and seek investment opportunities in a reputable company with a rich medical portfolio and a long history of innovation.

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Vasant Narasimhan

Employees

75,267

Headquarters

Basel

Valuation

Is today's price reasonable?

  • What speaks for it: The share price is below the Bulios Fair Price.

Growth and estimates

Is it growing, and what comes next?

  • What speaks for it: Earnings per share grew by 31% a year over the last 3 years.
  • What to watch: Earnings per share swing sharply from year to year.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What speaks for it: Out of every 100 USD of revenue, 23 USD is left as net profit.
  • What speaks for it: It earns 14 USD a year on every 100 USD of invested capital.

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy